• Citer

Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis

par Mori, Keiichiro;Schuettfort, Victor Maximilian;Yanagisawa, Takafumi;Katayama, Satoshi;Pradere, Benjamin;Laukhtina, Ekaterina;Rajwa, Pawel;Mostafaei, Hadi;Sari Motlagh, Reza;Quhal, Fahad;Moschini, Marco;Soria, Francesco;Teoh, Jeremy Yuen Chun;D'Andrea, David;Abufaraj, Mohammad;Albisinni, Simone ;Krajewski, Wojciech;Egawa, Shin;Karakiewicz, Pierre P.I.;Rink, Michael;Shariat, Shahrokh S.F.
Référence European Urology Focus
Publication Publié, 2022

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis
Auteur:	Mori, Keiichiro; Schuettfort, Victor Maximilian; Yanagisawa, Takafumi; Katayama, Satoshi; Pradere, Benjamin; Laukhtina, Ekaterina; Rajwa, Pawel; Mostafaei, Hadi; Sari Motlagh, Reza; Quhal, Fahad; Moschini, Marco; Soria, Francesco; Teoh, Jeremy Yuen Chun; D'Andrea, David; Abufaraj, Mohammad; Albisinni, Simone; Krajewski, Wojciech; Egawa, Shin; Karakiewicz, Pierre P.I.; Rink, Michael; Shariat, Shahrokh S.F.
Informations sur la publication:	European Urology Focus
Statut de publication:	Publié, 2022
Sujet CREF:	Néphrologie - urologie
Mots-clés:	Carboplatin
	Cisplatin
	Immune checkpoint inhibitors
	Platinum-based chemotherapy
	Urothelial carcinoma
Note générale:	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:2405-4569
	info:doi/10.1016/j.euf.2022.02.007
	info:pii/S2405456922000529
	info:scp/85126007954